Boots gender pay gap data is 5%, less than a third of national average

Boots gender pay gap data is 5%, less than a third of national average

March 26 2018 Boots has published data on its gender pay gap, indicating the pay gap benefits...

Prescription levy to rise to £8.80 from April 1 in England

Prescription levy to rise to £8.80 from April 1 in England

February 28 2018 The single NHS prescription charge will increase 20p to £8.80 per item...

Minister admits less than half of Pharmacy Integration Fund has been spent

Minister admits less than half of Pharmacy Integration Fund has been spent

December 19 2017 There has been a “significant underspend” of funding committed to...

£1m funding for pharmacist prescribing clinics in Scotland confirmed for 2017-18

£1m funding for pharmacist prescribing clinics in Scotland confirmed for 2017-18

September 20 2017 The Scottish Government has confirmed that £1 million will be available...

  • Boots gender pay gap data is 5%, less than a third of national average

    Boots gender pay gap data is 5%, less than a third of national average

    Monday, 26 March 2018 12:43
  • Prescription levy to rise to £8.80 from April 1 in England

    Prescription levy to rise to £8.80 from April 1 in England

    Wednesday, 28 February 2018 19:20
  • Minister admits less than half of Pharmacy Integration Fund has been spent

    Minister admits less than half of Pharmacy Integration Fund has been spent

    Tuesday, 19 December 2017 09:45
  • £1m funding for pharmacist prescribing clinics in Scotland confirmed for 2017-18

    £1m funding for pharmacist prescribing clinics in Scotland confirmed for 2017-18

    Wednesday, 20 September 2017 14:00

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

money notes pound coinsMay 16 2016

The Department of Health is to claim back £48 million from community pharmacies in England over Category M prices from June to September.

PSNC has said that the Department is introducing the price reductions to “reclaim excess margin that they believe was delivered to contractors in 2015-16 above the agreed allowed £800m. PSNC accepts that margin levels were high during the period, but has not agreed to the reduction.”

In its letter informing PSNC of the decision, the Department said that it felt its data was robust enough to support at least a £12 million a month reduction, and that a further review would be considered for October onwards. This would be in consultation with PSNC when the finalised 2015-16 medicine margin survey results are available, said PSNC. However, the Department’s projections “suggest that the October Drug Tariff is unlikely to see a significant recovery.”

Health and social care minister Alistair Burt has set out the amount of money that has been clawed back since 2005 when the Category M price category was introduced into the Drug Tariff. Lincoln MP Karl McCartney had asked in April “how much the Community Pharmacy Contractual Framework has accrued to the public purse through Category M savings since 2005.”

Mr Burt’s written answer last week said the adjustments to Category M generic medicine reimbursement prices have been made “to align total community pharmacy funding (including margin earned on the difference between reimbursement prices and purchase prices) with the target amount set for the community pharmacy contractual framework.

He included a table setting out the sums as follows:

table3

Links:

PSNC announcement

House of Commons written answer 36064

Finance News

July 20 2018 Community pharmacy representatives have briefed MPs about the role pharmacy teams can play in helping manage long term conditions.
July 20 2018 A consultation asking for views on how the safety features required under the Falsified Medicines Directive should be implemented has been issued. The MHRA has launched the consultation with...